TCDA logo

Tricida (TCDA) Stock

Profile

Full Name:

Tricida, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

28 June 2018

Indexes:

Not included

Description:

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 29, 2023

Recent annual earnings:

Mar 29, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with TCDA included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of Tricida?
  • What is the ticker symbol for Tricida?
  • Does Tricida pay dividends?
  • What sector is Tricida in?
  • What industry is Tricida in?
  • What country is Tricida based in?
  • When did Tricida go public?
  • Is Tricida in the S&P 500?
  • Is Tricida in the NASDAQ 100?
  • Is Tricida in the Dow Jones?
  • When was Tricida's last earnings report?
  • When does Tricida report earnings?

What is the primary business of Tricida?

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

What is the ticker symbol for Tricida?

The ticker symbol for Tricida is NASDAQ:TCDA

Does Tricida pay dividends?

No, Tricida does not pay dividends

What sector is Tricida in?

Tricida is in the Healthcare sector

What industry is Tricida in?

Tricida is in the Biotechnology industry

What country is Tricida based in?

Tricida is headquartered in United States

When did Tricida go public?

Tricida's initial public offering (IPO) was on 28 June 2018

Is Tricida in the S&P 500?

No, Tricida is not included in the S&P 500 index

Is Tricida in the NASDAQ 100?

No, Tricida is not included in the NASDAQ 100 index

Is Tricida in the Dow Jones?

No, Tricida is not included in the Dow Jones index

When was Tricida's last earnings report?

Tricida's most recent earnings report was on 29 March 2023

When does Tricida report earnings?

The date for Tricida's next earnings report has not been announced yet